Low-dose tofacitinib with 308-nm excimer therapy successfully induced repigmentation in patients with refractory vitiligo.

Authors :: Fang WC
Lin SY
Huang SM
Lan CE
Source :: Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Apr; Vol. 47 (4), pp. 782-783. Date of Electronic Publication: 2022 Jan 05.
Publication Year :: 2022
Abstract: Combining low-dose tofacitinib with 308-nm excimer may be an effective treatment for patients with nonsegmental vitiligo who were refractory to conventional therapies.<br /> (© 2021 British Association of Dermatologists.)

Subjects :: Humans
Piperidines
Pyrimidines
Treatment Outcome
Low-Level Light Therapy
Vitiligo radiotherapy

Full Text Access

Tools